Disclosures: Nicole Kim: Madrigal: Grant/Research Support, Muyi Li: Nothing to Disclose, Philip Vutien: Nothing to Disclose, Joleen Borgerding: Nothing to Disclose, Abbey Barnard Giustini: Nothing to Disclose, Kay Johnson: Nothing to Disclose, Kristin Berry Wyatt: Nothing to Disclose, Catherine Mezzacappa: Nothing to Disclose, Tamar Taddei: Nothing to Disclose, David Kaplan: AstraZeneca Inc: Grant/Research Support, Roche Genentech: Independent Contractor, Exact Sciences: Grant/Research Support, Glycotest: Grant/Research Support, Sirtex: Advisor, Exelixis: Advisor, AstraZeneca: Advisor, George Ioannou: Nothing to Disclose 1838 THE CHEMOPROTECTIVE EFFECTS OF GENISTEIN IN A RAT MODEL OF CIRRHOSIS AND HEPATOCELLULAR CARCINOMA Maneerat Chayanupatkul 1 Duangporn Werawatganon 2 Natcha Wanpiyarat 2 , 1 Faculty of Medicine, Chulalongkorn University, 2 Chulalongkorn University Background: Liver cancer is the sixth most common cancer and the third most common cause of cancer-related mortality worldwide

Another study had shown significantly increased levels of OS in schizophrenic patients, which is indicated by higher levels of pro-oxidants NO and MDA, and declined levels of antioxidants GSH, SOD, GPX and neurotrophins (NT) 4/5 (Dietrich-Muszalska and Kwiatkowska, 2014)
This consultation allows our medical team to review your history and determine which therapies are truly right for you
Hypotheses 143:110102